Neuromuscular Studies

Identification of Diagnostic and Prognostic Biomarkers from Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples

The main purpose of the study is to collect tissue samples for genetic and biomarker analysis.

Qualified participants will

• Have a diagnosis of ALS
• Will be undergoing a scheduled feeding tube placement at UMC

For more information, see the contact information below.

3,4 diaminopyridine for Lambert-Eaton Myasthenic Syndrome and Congenital Myasthenic Syndromes

The purpose of this study is to provide symptomatic treatment for patients with LEMS and CMS with the medication 3,4 DAP. This medication enhances the effects of pyridostigmine.

Qualified participants will

• Have a confirmed diagnosis of LEMS or CMS
• Will have significant symptomatic weakness despite treatment with immune therapy or pyridostigmine
• Children or adults are welcome to participate

For more information, see the contact information below.

Alglucosidase Alfa Temporary Access Program

The purpose of this study is to provide enzyme replacement therapy to patients with Pompe disease. This study currently running but is closed to new subject enrollment.

For more information about the above research studies, please contact Dr. Katalin Scherer (520-874-2747 or ).